Question 1

Does Béa Fertility treat single women seeking fertility treatment?

Accepted Answer

Yes, Béa Fertility explicitly supports single women who wish to become parents by choice. The at‑home treatment pathway is designed for individuals without a partner, offering donor sperm insemination, detailed ovulation tracking, and step‑by‑step guidance from a dedicated fertility nurse. Single users receive the same FDA‑cleared applicator, video consultation with a reproductive specialist, and unlimited access to the Treatment Hub, ensuring personalized fertility treatment without clinic visits. Eligibility criteria include being over 18, having regular menstrual cycles, and no contraindicating medical conditions, making Béa a viable assisted reproduction option for solo mothers‑by‑choice.

Question 2

Does Béa Fertility provide fertility treatment for same-sex couples?

Accepted Answer

Béa Fertility offers dedicated fertility treatment programs for same‑sex female couples. The service includes donor sperm insemination using the FDA‑cleared Béa Applicator, comprehensive ovulation monitoring, and personalized care from a fertility clinician and a dedicated nurse. Couples receive video consultations, unlimited access to the Treatment Hub, and two insemination attempts per cycle to maximize the chance of conception. The platform also provides legal guidance on donor screening and documentation, ensuring a supportive and inclusive environment for LGBTQ+ families seeking assisted reproduction before considering more invasive options such as IVF.

Question 3

Who are the fertility doctors and specialists at Béa Fertility?

Accepted Answer

Béa Fertility’s medical leadership includes a distinguished advisory board of reproductive specialists. Dr. Jane Van Dis, M.D., serves as an assistant professor of obstetrics and gynecology at the University of Rochester Medical Center, bringing extensive expertise in fertility treatment and assisted reproduction. Dr. T. Mike Hsieh, M.D., MBA, is a professor of urology and director of the Men’s Health Center at UCSD, providing deep insight into male factor infertility. Dr. Charlotte Hastings, a board‑certified OB/GYN at Dartmouth Hitchcock Medical Center, contributes clinical oversight of female reproductive health. Finally, Dr. Somi Javaid, M.D., Chief Medical Officer and founder of HerMD, guides the overall clinical strategy. Together with a dedicated fertility nurse and a team of certified fertility specialists, Béa ensures patients receive professional reproductive endocrinology support throughout their at‑home treatment.

Question 4

What is the history and background of Béa Fertility?

Accepted Answer

Béa Fertility was founded in 2021 by a team of leading clinicians in London, aiming to fill the “wait‑and‑see” gap in early‑stage fertility care. After two years of research and development, the company launched in the UK in 2023, introducing its fourth‑generation, FDA‑cleared applicator after 90 prototypes and over 1,000 tests. In 2024, Béa published efficacy data showing a 39.28% pregnancy rate across 3,500+ cycles and 1,250+ patients. By 2025, the platform achieved Class II FDA clearance, expanded to all 50 U.S. states for its Essential Care option, and secured a robust medical advisory board. Throughout its growth, Béa has emphasized affordable, evidence‑based assisted reproduction, positioning itself as a bridge between natural conception and in vitro fertilization.

Question 5

What fertility treatments and services does Béa Fertility offer?

Accepted Answer

Béa Fertility delivers a comprehensive at‑home fertility treatment package that combines clinical care with FDA‑cleared technology. The core service is the Béa Treatment, which includes a precision applicator that places semen directly onto the cervix, delivering up to 3.23 × more sperm than timed intercourse and supporting natural conception without injections or clinic visits. Patients receive a video consultation with a fertility clinician, unlimited access to a secure Treatment Hub, and a dedicated fertility nurse for real‑time guidance via text, email, or calls. The program supports heterosexual couples, same‑sex female couples, and single women, offering tailored protocols for donor sperm insemination, ovulation tracking, and two insemination attempts per cycle. All kits are HSA/FSA‑eligible, and the service bridges the gap between natural TTC and more invasive assisted reproduction such as IVF.

Question 6

What are the IVF success rates at Béa Fertility?

Accepted Answer

Béa Fertility reports a pregnancy rate of 39.28% across up to three treatment cycles, based on an internal observational study of 56 users who completed the protocol between June and December 2023. This figure reflects reported pregnancies during or after the at‑home insemination cycles and is comparable to typical intrauterine insemination (IUI) success rates in similar populations, offering a viable bridge before considering in vitro fertilization (IVF) or other assisted reproduction options. The data include participants with an average age of 37.6, a mix of gynecological conditions, and a subset who had previously tried IVF or IUI, underscoring the relevance of Béa’s success rate for a broad range of fertility journeys.

Béa Fertility

About Béa Fertility

Béa Fertility — Patient Reviews

Béa Fertility — FAQ

Contact & Location

More Fertility Clinics in United Kingdom

P4 Fertility

IVF London

abc ivf